DK294489A - Oralt indgiveligt laegemiddelpraeparat af buspiron og salte deraf - Google Patents

Oralt indgiveligt laegemiddelpraeparat af buspiron og salte deraf Download PDF

Info

Publication number
DK294489A
DK294489A DK294489A DK294489A DK294489A DK 294489 A DK294489 A DK 294489A DK 294489 A DK294489 A DK 294489A DK 294489 A DK294489 A DK 294489A DK 294489 A DK294489 A DK 294489A
Authority
DK
Denmark
Prior art keywords
salts
buspiron
oral substances
oral
substances
Prior art date
Application number
DK294489A
Other languages
Danish (da)
English (en)
Other versions
DK294489D0 (da
Inventor
Alf Gunnar Martin Nicklasson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of DK294489A publication Critical patent/DK294489A/da
Publication of DK294489D0 publication Critical patent/DK294489D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK294489A 1987-10-22 1989-06-15 Oralt indgiveligt laegemiddelpraeparat af buspiron og salte deraf DK294489D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8704097A SE8704097D0 (sv) 1987-10-22 1987-10-22 Oral formulation of buspirone and salts thereof
PCT/SE1988/000543 WO1989003676A1 (en) 1987-10-22 1988-10-17 Oral formulation of buspirone and salts thereof

Publications (2)

Publication Number Publication Date
DK294489A true DK294489A (da) 1989-06-15
DK294489D0 DK294489D0 (da) 1989-06-15

Family

ID=20369959

Family Applications (1)

Application Number Title Priority Date Filing Date
DK294489A DK294489D0 (da) 1987-10-22 1989-06-15 Oralt indgiveligt laegemiddelpraeparat af buspiron og salte deraf

Country Status (21)

Country Link
EP (1) EP0313535B1 (hu)
JP (1) JP2674170B2 (hu)
KR (1) KR970004906B1 (hu)
AT (1) ATE108997T1 (hu)
AU (1) AU604585B2 (hu)
CY (1) CY1814A (hu)
DE (1) DE3850844T2 (hu)
DK (1) DK294489D0 (hu)
ES (1) ES2056955T3 (hu)
FI (1) FI100303B (hu)
HK (1) HK21295A (hu)
HU (1) HU204998B (hu)
IE (1) IE64705B1 (hu)
IL (1) IL88020A (hu)
NO (1) NO892512L (hu)
NZ (1) NZ226604A (hu)
PT (1) PT88820B (hu)
SE (1) SE8704097D0 (hu)
WO (1) WO1989003676A1 (hu)
YU (1) YU47903B (hu)
ZA (1) ZA887624B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208495B (en) * 1990-06-27 1993-11-29 Alkaloida Vegyeszeti Gyar Process for producing retarde pharmaceutical compositions
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
DE4341156C2 (de) * 1993-12-02 1997-11-13 Wacker Chemie Gmbh Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
CN1178659C (zh) * 1997-09-25 2004-12-08 拜尔公司 控释活性化合物的药物制剂
US6268368B1 (en) * 2000-03-01 2001-07-31 American Pharmaceuticals International Anionic exchange polymer complexes of buspirone
CN117257747B (zh) * 2023-11-21 2024-01-30 泊诺(天津)创新医药研究有限公司 一种盐酸丁螺环酮片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
SE353229B (hu) * 1970-06-04 1973-01-29 Haessle Ab
US4182703A (en) * 1978-01-09 1980-01-08 Eastman Kodak Company Biheterocyclic ultraviolet stabilizers and their use in organic compositions
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4693895A (en) * 1984-10-26 1987-09-15 Alza Corporation Colon delivery system
US4634703A (en) * 1985-10-25 1987-01-06 Bristol-Myers Company Method for alleviation of panic disorders
US4640921A (en) * 1986-02-04 1987-02-03 Bristol-Myers Treatment of sexual dysfunction with buspirone

Also Published As

Publication number Publication date
YU196488A (en) 1990-04-30
SE8704097D0 (sv) 1987-10-22
ZA887624B (en) 1989-06-28
EP0313535B1 (en) 1994-07-27
KR890701087A (ko) 1989-12-19
FI893017A (fi) 1989-06-20
HUT54495A (en) 1991-03-28
PT88820B (pt) 1993-01-29
JPH02501744A (ja) 1990-06-14
EP0313535A1 (en) 1989-04-26
FI100303B (fi) 1997-11-14
CY1814A (en) 1995-10-20
IE883177L (en) 1989-04-22
DK294489D0 (da) 1989-06-15
HK21295A (en) 1995-02-24
DE3850844T2 (de) 1994-12-08
AU2623688A (en) 1989-05-23
WO1989003676A1 (en) 1989-05-05
ATE108997T1 (de) 1994-08-15
KR970004906B1 (ko) 1997-04-08
IL88020A0 (en) 1989-06-30
IE64705B1 (en) 1995-08-23
DE3850844D1 (de) 1994-09-01
ES2056955T3 (es) 1994-10-16
YU47903B (sh) 1996-05-20
IL88020A (en) 1993-08-18
NO892512D0 (no) 1989-06-16
NZ226604A (en) 1991-07-26
HU204998B (en) 1992-03-30
AU604585B2 (en) 1990-12-20
NO892512L (no) 1989-06-16
JP2674170B2 (ja) 1997-11-12
FI893017A0 (fi) 1989-06-20
HU886266D0 (en) 1991-01-28

Similar Documents

Publication Publication Date Title
BR8707937A (pt) Protese para osteosintese
DK263288D0 (da) Farmaceutisk praeparat af cefuroxim-axetil
NO883506D0 (no) Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater.
DK0593639T3 (da) Pyrrolidin- og thiazolidinderivater, fremstilling af disse forbindelser og lægemidler indeholdende disse
NO892642D0 (no) Acyldeoksyribonukleosidderivater og anvendelse derav.
ATE131050T1 (de) Matrixtablette zur verlängerten indapamidfreisetzung nach oraler gabe.
DK164917C (da) Analogifremgangsmaade til fremstilling af bicyklisk substituerede dipeptidderivater og deres farmaceutisk acceptable salte
DK294489D0 (da) Oralt indgiveligt laegemiddelpraeparat af buspiron og salte deraf
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
DK122191A (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
DK559288A (da) Farmaceutisk praeparat for piperidinoalkanolderivater
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
DK522986A (da) Fremgangsmaade til indgift af ethanolaminderivater til husdyr
DK160478A (da) Fremgangsmaade til fremstilling af 3-(1-piperazinyl)-1,2,4-benzotriaziner,n-oxider og pharmaceutisk acceptable salte deraf
ES2041790T3 (es) Derivados de tetrahidroisoquinolina amino-substituidos y su procedimiento de obtencion.
NO870950D0 (no) Fremgangsmaate for fremstilling av et stabilt injiserbart farmasoeytisk preparat.
NO172120C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler
MX10256A (es) Procedimiento para preparar nuevas 3-fenil-7h-tiazolo(3, 2-b) (1, 2, 4) triazin-7-onas.
BR6702179U (pt) Articulador para protese dentaria
DK189291D0 (da) 3h-purin-2,6-dionderivater og salte deraf, farmaceutisk praeparat indeholdende dem samt fremstilling af derivater og praeparat
DK511788D0 (da) Fremgangsmaade til fodring af droevtyggere
IT8722572A0 (it) Apparecchio medicale per iniezione controllata di medicinali.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment